200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 69-81-8
69-81-8 | 2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide
CAS No: 69-81-8 Catalog No: AG003ETW MDL No:MFCD00059705
Product Description
Catalog Number:
AG003ETW
Chemical Name:
2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide
CAS Number:
69-81-8
Molecular Formula:
C10H12N4O3
Molecular Weight:
236.2273
MDL Number:
MFCD00059705
IUPAC Name:
(3,6-dihydroxy-1-methyl-2,3-dihydroindol-5-yl)iminourea
InChI:
InChI=1S/C10H12N4O3/c1-14-4-9(16)5-2-6(12-13-10(11)17)8(15)3-7(5)14/h2-3,9,15-16H,4H2,1H3,(H2,11,17)
InChI Key:
SSCSSDNTQJGTJT-UHFFFAOYSA-N
SMILES:
NC(=O)N/N=C\1/C=C2C(O)CN(C2=CC1=O)C
EC Number:
200-717-0
NSC Number:
73742
Properties
Complexity:
336
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
236.091g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
236.231g/mol
Monoisotopic Mass:
236.091g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
112A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
XLogP3:
0
Literature
| Title | Journal |
|---|---|
| Determination of carbazochrome by fluorescence quenching method. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121101 |
| Prospective multicenter study of visual outcomes following three different treatments for macular edema associated with branch retinal vein occlusion: a study by the Japanese BRVO study group. | Japanese journal of ophthalmology 20120501 |
| Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. | The Journal of arthroplasty 20120101 |
| Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro. | Biochemistry 20101214 |
| Development and validation of a robust LC-MS-MS with atmospheric pressure chemical ionization for quantitation of carbazochrome sodium sulfonate in human plasma: application to a pharmacokinetic study. | Biomedical chromatography : BMC 20100901 |
| Effect of furosemide and furosemide-carbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses. | The Canadian veterinary journal = La revue veterinaire canadienne 20090801 |
| Short-term delayed-release microcapsules spraycoated with acrylic terpolymers. | International journal of pharmaceutics 20060113 |
| Dengue fever. | Clinical evidence 20050601 |
| Carbazochrome sodium sulfonate (AC-17) reverses endothelial barrier dysfunction through inhibition of phosphatidylinositol hydrolysis in cultured porcine endothelial cells. | Naunyn-Schmiedeberg's archives of pharmacology 20030901 |
| Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndrome. | American journal of hematology 20030101 |
| [A 50-year history of new drugs in Japan-the development and trends of hemostatics and antithrombotic drugs]. | Yakushigaku zasshi 20030101 |
| [Case of pulmonary actinomycosis refractory to therapy]. | The Japanese journal of antibiotics 20021201 |
| Carbazochrome attenuates pulmonary dysfunction induced by a radiographic contrast medium in rats. | European journal of pharmacology 20020823 |
| Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study. | Current medical research and opinion 20010101 |
| Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids. | European review for medical and pharmacological sciences 20000101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.